PHARMACEUTICALS PRODUCED TRANSGENIC

Brand	Owner	Address	Description
MAGNAKINES	AviGenics, inc.	425 River Road Athens GA 306022771	Pharmaceuticals produced in a transgenic avian platform for human use for use in the treatment of diseases caused by immune system disorders;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The invention provides a transgenic pig having incorporated into its genome a HSP70 gene or fragment thereof, whereby the transgenic pig overexpresses HSP70. The transgenic pig of the invention can be used in the production of HSP in large quantities, as a xenograft source for transplation and as an animal model close to human for illustrating the protective roles of HSP. Furthermore, the transgenic pig of the invention has a better meat quality and exhibits an increased growth rate and a reduced backfat thickness.